1. Home
  2. GPMT vs TXMD Comparison

GPMT vs TXMD Comparison

Compare GPMT & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPMT
  • TXMD
  • Stock Information
  • Founded
  • GPMT 2015
  • TXMD 2008
  • Country
  • GPMT United States
  • TXMD United States
  • Employees
  • GPMT N/A
  • TXMD N/A
  • Industry
  • GPMT Real Estate Investment Trusts
  • TXMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • GPMT Real Estate
  • TXMD Health Care
  • Exchange
  • GPMT Nasdaq
  • TXMD Nasdaq
  • Market Cap
  • GPMT 126.8M
  • TXMD 12.8M
  • IPO Year
  • GPMT 2017
  • TXMD N/A
  • Fundamental
  • Price
  • GPMT $2.57
  • TXMD $1.18
  • Analyst Decision
  • GPMT Buy
  • TXMD
  • Analyst Count
  • GPMT 3
  • TXMD 0
  • Target Price
  • GPMT $2.75
  • TXMD N/A
  • AVG Volume (30 Days)
  • GPMT 1.0M
  • TXMD 45.8K
  • Earning Date
  • GPMT 08-04-2025
  • TXMD 08-11-2025
  • Dividend Yield
  • GPMT 7.78%
  • TXMD N/A
  • EPS Growth
  • GPMT N/A
  • TXMD N/A
  • EPS
  • GPMT N/A
  • TXMD N/A
  • Revenue
  • GPMT N/A
  • TXMD $1,841,000.00
  • Revenue This Year
  • GPMT N/A
  • TXMD $427.09
  • Revenue Next Year
  • GPMT $31.11
  • TXMD N/A
  • P/E Ratio
  • GPMT N/A
  • TXMD N/A
  • Revenue Growth
  • GPMT N/A
  • TXMD 53.55
  • 52 Week Low
  • GPMT $1.61
  • TXMD $0.70
  • 52 Week High
  • GPMT $3.66
  • TXMD $2.44
  • Technical
  • Relative Strength Index (RSI)
  • GPMT 54.36
  • TXMD 48.98
  • Support Level
  • GPMT $2.38
  • TXMD $0.98
  • Resistance Level
  • GPMT $2.73
  • TXMD $1.21
  • Average True Range (ATR)
  • GPMT 0.14
  • TXMD 0.09
  • MACD
  • GPMT -0.01
  • TXMD 0.01
  • Stochastic Oscillator
  • GPMT 66.67
  • TXMD 80.00

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: